• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血干细胞移植后正常皮肤和慢性移植物抗宿主病中朗格汉斯细胞的起源。

Origin of Langerhans cells in normal skin and chronic GVHD after hematopoietic stem-cell transplantation.

作者信息

Andani Rafiq, Robertson Ivan, Macdonald Kelli P A, Durrant Simon, Hill Geoffrey R, Khosrotehrani Kiarash

机构信息

Experimental Dermatology Laboratory, UQ Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia.

出版信息

Exp Dermatol. 2014 Jan;23(1):75-7. doi: 10.1111/exd.12301.

DOI:10.1111/exd.12301
PMID:24313654
Abstract

Chronic graft-versus-host disease (cGVHD) is a common complication following allogeneic stem-cell transplantation (SCT). Past studies have implicated the persistence of host antigen-presenting cells (APCs) in GVHD. Our objective was to determine the frequency of host Langerhans cells (LCs) in normal skin post-SCT and ask if their persistence could predict cGVHD. Biopsies of normal skin from 124 sex-mismatched T-cell-replete allogenic SCT recipients were taken 100 days post-transplant. Patients with acute GVHD and those with <9 months of follow-up were excluded and prospective follow-up information was collected from remaining 22 patients. CD1a staining and X and Y chromosome in-situ hybridization were performed to label LCs and to identify their host or donor origin. At 3 months, 59 ± 5% of LCs were host derived. The density of LCs and the proportion of host-derived LCs were similar between patients that did or did not develop cGVHD. Most LCs in the skin remained of host origin 3 months after SCT regardless of cGVHD status. This finding is in line with the redundant role of LCs in acute GVHD initiation uncovered in recent experimental models.

摘要

慢性移植物抗宿主病(cGVHD)是异基因干细胞移植(SCT)后的常见并发症。既往研究表明移植物抗宿主病中宿主抗原呈递细胞(APC)持续存在。我们的目的是确定SCT后正常皮肤中宿主朗格汉斯细胞(LC)的频率,并探讨其持续存在是否可预测cGVHD。对124例性别不匹配且T细胞充足的异基因SCT受者在移植后100天进行正常皮肤活检。排除急性移植物抗宿主病患者及随访时间<9个月的患者,并从其余22例患者收集前瞻性随访信息。进行CD1a染色及X和Y染色体原位杂交以标记LC并确定其宿主或供体来源。在3个月时,59±5%的LC来源于宿主。发生或未发生cGVHD的患者之间,LC的密度及宿主来源LC的比例相似。无论cGVHD状态如何,SCT后3个月皮肤中的大多数LC仍来源于宿主。这一发现与近期实验模型中揭示的LC在急性移植物抗宿主病起始中的冗余作用一致。

相似文献

1
Origin of Langerhans cells in normal skin and chronic GVHD after hematopoietic stem-cell transplantation.造血干细胞移植后正常皮肤和慢性移植物抗宿主病中朗格汉斯细胞的起源。
Exp Dermatol. 2014 Jan;23(1):75-7. doi: 10.1111/exd.12301.
2
Frequent detection of herpes simplex virus antigen in skin and peripheral blood CD34+ mononuclear cells from patients with graft-versus-host disease.频繁检测到移植物抗宿主病患者皮肤和外周血 CD34+ 单核细胞中的单纯疱疹病毒抗原。
Biol Blood Marrow Transplant. 2013 Apr;19(4):529-37. doi: 10.1016/j.bbmt.2012.12.021. Epub 2013 Jan 11.
3
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
4
Langerhans cell homeostasis and turnover after nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation.非清髓性和清髓性异基因造血细胞移植后朗格汉斯细胞的稳态与更新
Transplantation. 2014 Sep 15;98(5):563-8. doi: 10.1097/TP.0000000000000097.
5
Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.同种异体造血干细胞移植后患者的慢性移植物抗宿主病的肾脏表现。
Eur J Haematol. 2013 Aug;91(2):129-34. doi: 10.1111/ejh.12149. Epub 2013 Jun 28.
6
The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.B 系急性淋巴细胞白血病异基因干细胞移植后,急性和慢性移植物抗宿主病对正常及恶性 B 淋巴细胞前体的影响
Haematologica. 2006 Mar;91(3):340-7.
7
Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.接受异基因造血干细胞移植患者中CD3+嵌合状态动力学与移植物抗宿主病发生率之间的相关性
Transplant Proc. 2011 Jun;43(5):1915-23. doi: 10.1016/j.transproceed.2011.02.011.
8
Quantitative analysis of Langerhans' cells in oral chronic graft-vs.-host disease.口腔慢性移植物抗宿主病中朗格汉斯细胞的定量分析
J Oral Pathol Med. 2009 Jan;38(1):132-7. doi: 10.1111/j.1600-0714.2008.00712.x. Epub 2008 Nov 11.
9
Early-onset lichenoid graft-vs.-host disease: a unique variant of acute graft-vs.-host disease occurring in peripheral blood stem cell transplant recipients.早发性苔藓样移植物抗宿主病:外周血干细胞移植受者中发生的一种独特的急性移植物抗宿主病变体。
J Cutan Pathol. 2010 May;37(5):549-58. doi: 10.1111/j.1600-0560.2009.01427.x. Epub 2009 Oct 15.
10
A question of persistence: Langerhans cells and graft-versus-host disease.持续性问题:朗格汉斯细胞与移植物抗宿主病。
Exp Dermatol. 2014 Apr;23(4):234-5. doi: 10.1111/exd.12325.

引用本文的文献

1
STR typing of skin swabs from individuals after an allogeneic hematopoietic stem cell transplantation.对异基因造血干细胞移植后个体的皮肤拭子进行 STR 分型。
Int J Legal Med. 2023 Jan;137(1):227-236. doi: 10.1007/s00414-022-02847-5. Epub 2022 Jun 3.
2
Langerhans cell origin and regulation.朗格汉斯细胞的起源与调控。
Curr Opin Hematol. 2016 Jan;23(1):28-35. doi: 10.1097/MOH.0000000000000202.
3
Dendritic Cell Therapy in an Allogeneic-Hematopoietic Cell Transplantation Setting: An Effective Strategy toward Better Disease Control?
异基因造血细胞移植环境中的树突状细胞疗法:实现更好疾病控制的有效策略?
Front Immunol. 2014 May 19;5:218. doi: 10.3389/fimmu.2014.00218. eCollection 2014.
4
A question of persistence: Langerhans cells and graft-versus-host disease.持续性问题:朗格汉斯细胞与移植物抗宿主病。
Exp Dermatol. 2014 Apr;23(4):234-5. doi: 10.1111/exd.12325.